https://www.selleckchem.com/pr....oducts/tetrazolium-r
5 to 1 year (67%) than did those not receiving nutrition therapy (48%; RR 1.32, 95% CI 1.07-1.64, P = .01). The total adverse event rate was comparable in the two groups (RR 3.60, 95% CI 0.70-18.66, P = .13). PEN may be more effective than the absence of EN therapy for the maintenance of remission in CD with a good safety profile.In this study, a series of 1,3,4-oxadiazole derivatives (5a-s, 10a-s, and 16a-d) were designed and synthesized using maximal electroshock (MES) and subcutaneous pentylenetetrazole (scPTZ) models, to tes
Like
Comment
Share
